Mobile menu icon
Mobile menu icon Search iconSearch
Search type
Man looking at data on a laptop

Model-based Drug Development (MSc)

Our MSc focuses on the broad range of issues that make up modelling and simulation efforts during drug development.

Model-based Drug Development Overview

Year of entry: 2017

View tabs | View full page


Our Model-based Drug Development MSc reinforces the issues involved with modelling and simulation in drug development via hands-on application of the skills to real-world data.

The course is suitable if you are a scientist already working in the pharmaceutical industry who wishes to qualify as a modeller with hands-on experience.

Learn more

More information on this course is below, including details of how to apply. If you would like to sign up for advice on the application process or ask a specific question, please fill in our online contact form.

Degree awarded
12 months FT or 24 months PT
Entry requirements

For the MSc, applicants require a relevant university first degree from a reputable internationally recognised institution (as determined by the PG Office at the University of Manchester). The minimum class degree should be 2.2 or its equivalent.

For individual CPD modules, there are no specific entry requirements other than relevant industry experience.

Full entry requirements

Number of places/applicants
There are a maximum of 15 places available.
Contact email
Contact telephone
+44 (0)161 306 0604
How to apply

Apply online

Contact us if you need more information or to arrange a discussion with the programme director.

Course options

Full-timePart-timeFull-time distance learningPart-time distance learning

Course description

Our MSc Model-based Drug Development course provides the knowledge and skills for making evidence-based decisions at various stages of drug development.

It covers the scientific and regulatory aspects of evaluating a drug, with emphasis on the use of modelling and simulation methods. You will learn why these methods are so highly valued by industry and regulatory authorities as effective, cost-saving, decision-making tools. Learning is reinforced via hands-on application of the skills to real data.

The course has been developed with an emphasis on mechanistic approaches to assessing and predicting pharmacokinetics and pharmacodynamics (PKPD), such as physiologically-based pharmacokinetics (PBPK) .

As this comes under the general umbrella of systems biology, you will be able to apply your knowledge of modelling and simulation in various areas of research within the pharmaceutical industry.

Full-time students benefit from immersion in the varied biomedical research environment at The University of Manchester, including interaction with research staff at the renowned Centre for Applied Pharmacokinetic Research .

Alternatively, part-time students already working in the pharmaceutical industry can take advantage of the flexible, distance learning mode of the course, which allows you to fit study around other commitments.


For entry in the academic year beginning September 2017, the tuition fees are as follows:

  • MSc (full-time)
    UK/EU students (per annum): £12,000
    International students (per annum): £21,500
  • MSc (part-time distance learning)
    UK/EU students: £6,000 per annum
    International students: £10,750 per annum

The fees quoted above will be fully inclusive for the course tuition, administration and computational costs during your studies.

All fees for entry will be subject to yearly review and incremental rises per annum are also likely over the duration of courses lasting more than a year for UK/EU students (fees are typically fixed for International students, for the course duration at the year of entry). For general fees information please visit: postgraduate fees . Always contact the department if you are unsure which fee applies to your qualification award and method of attendance.